C |
Estimated cost for all participants for 1 year of program exposure (societal perspective, $) |
828,069 |
684,363 |
1,162,468 |
716,127 |
442,035 |
339,155 |
399,956 |
T |
Treatment cost of one HIV infection from the literature (2013 dollars, $) |
350,509 |
350,509 |
350,509 |
350,509 |
350,509 |
350,509 |
350,509 |
A |
Estimated number of person-years of viral suppression (A1) |
33 |
40 |
39 |
14 |
37 |
96 |
18 |
Estimated number of HIV infections averted (A2) |
1.54 |
1.91 |
1.84 |
0.64 |
1.74 |
4.54 |
0.87 |
Q * A |
QALYs saved through improved individual health (Q1 = A1 * 0.039) |
1.27 |
1.58 |
1.52 |
0.53 |
1.43 |
3.74 |
0.72 |
QALYs saved through averted HIV infections (Q2 = A2 * 5.83) |
9.00 |
11.14 |
10.71 |
3.73 |
10.14 |
26.46 |
5.09 |
Total QALYs saved (Q1 + Q2) |
10.27 |
12.72 |
12.23 |
4.26 |
11.57 |
30.20 |
5.81 |
Cost–utility ratio [R = (C − AT)/AQ] ($) |
27,906.99 |
1127.70 |
42,427.91 |
115,467.92 |
(14,470.95) |
(41,439.51) |
16,181.94 |
Interpretation of cost– utility ratio |
Cost-effective |
Cost-effective |
Cost-effective |
Cost-effective |
Cost-saving |
Cost-saving |
Cost-effective |